ATRA icon

Atara Biotherapeutics

82 hedge funds and large institutions have $57.9M invested in Atara Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 28 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

15% less call options, than puts

Call options by funds: $33K | Put options by funds: $39K

29% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 24

Holders
82
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$33K
Puts
$39K
Net Calls
Net Calls Change

Top Buyers

1 +$4.44M
2 +$4.34M
3 +$3.4M
4
BC
Boxer Capital
California
+$2.88M
5
VPC
Vestal Point Capital
New York
+$1.94M

Top Sellers

1 -$2.49M
2 -$1.78M
3 -$1.55M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.16M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$581K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$7.06M
2
$6.43M
3
$4.74M
4
$4.57M
5
$4.52M
6
$3.48M
7
$3.44M
8
$2.88M
9
$1.94M
10
$1.83M
11
$1.82M
12
$1.73M
13
$1.5M
14
$1.3M
15
$1.23M
16
$938K
17
$934K
18
$694K
19
$685K
20
$680K
21
$620K
22
$590K
23
$528K
24
$304K
25
$303K